Research Australia’s Pre Budget submission to the Treasurer ahead of the 2024 Budget has made the case for increased investment in Australian health and medical research and innovation to support a healthier and more prosperous Australia.
The Australian Government’s investment in R&D is below the OECD average.
There is an additional $323 million approved for release from the MRFF in 2024-25 that the Government is not investing in medical research and innovation.
The Universities Accord process provides the ideal opportunity to increase the investment in the NHMRC, ARC and indirect research costs.
We have advocated for a greater role for the Australian Centre for Disease Control, for the greater use of Government procurement to support Australian innovation, and for the full development of the National HMR strategy and workforce strategy.
Read Research Australia’s submission here.